How smart are you about your health? Do you know your cholesterol number? What’s your blood pressure? How’s your glucose level? Not that long ago, these were the questions. Today, those questions and more are being answered by a source other than doctors or other healthcare providers. Fitbits, health patches, remote monitoring devices, contact lenses, as well as other technologies are driving in-home care, at-workplace care, and in-car care. As Robin Robinson discusses in this month’s cover story, these personal smart technologies are improving prevention, detection, behavior change, and caregiver support.
The virtual aspect of healthcare is expected to continue to gain acceptability. According to a recent EY report, consumers will increasingly conduct virtual visits with doctors, nurses, and care coaches through cell phones, tablets, and laptops over the next decade. Not only will smart technologies help improve the quality of life for patient-consumers, but the data generated will increasingly be used to help inform drug development, clinical trials, and care delivery.
Designed to facilitate coordinated care across the continuum from healthy living and prevention, to diagnosis and treatment, to home care, this emerging trend represents a two-fold opportunity for pharma companies: creating solutions that enhance patient outcomes and gaining access to de-identified patient-generated data that can guide drug development and business strategies.
As this month’s forum details, organizations such as Philips and Validic are collaborating to create connected health solutions that deliver patient information to physicians using health data that are being generated within a clinical setting as well as remotely.
And for patients there is also an opportunity in terms of a financial incentive to become smart health savvy. Recently, UnitedHealthcare and Qualcomm launched a new wellness program that provides members with wearable devices at no additional charge and enables them to earn money by meeting certain goals for the number of daily steps. The collaboration focuses on UnitedHealthcare programs and services that incorporate the latest generation of wearables, medical devices, and home diagnostic tests that use Qualcomm Life’s 2net Platform for medical-grade connectivity. The wellness program and related fitness trackers are being offered initially to companies with 101 to 300 employees with a fully insured health plan. Unlike other wearable devices that simply track the total number of steps, the UnitedHealthcare Motion devices tabulate the total number, frequency, and intensity of the steps taken, providing a more accurate and comprehensive summary of the user’s daily activity. Employees can earn Health Reimbursement Account credits that can total up to $1,460 per year, while employers can obtain premium savings based on program participants’ combined results.
Hey, have you hit your 10,000 steps today?
The new technology is not a cure for paralysis. Mr. Burkhart could use his hand only when connected to computers in the lab, and the researchers said there was much work to do before the system could provide significant mobile independence.
But the field of neural engineering is advancing quickly. Using brain implants, scientists can decode brain signals and match them to specific movements. Previously, people have learned to guide a cursor on a screen with their thoughts, primates have learned to skillfully use a robotic arm using only neural signals and scientists have shown in primates that thoughts can move arm muscles. This new study demonstrates that the bypass approach can restore critical skills to limbs no longer directly connected to the brain.
Researchers are hopeful that a successful HIV vaccine is a real possibility in the foreseeable future.
As the role of the MSL grows in significance, training becomes crucial.
India is a fast-growing and dynamic market with many opportunities for pharmaceutical companies – both local and multinational.
Volume 16 • Number 5
Publisher Lisa Banket
Editor Taren Grom
Creative Director Marah Walsh
Director of Sales
National Account Manager
Webcast Network Producer
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Sixteen, Number Five
PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by PharmaLinx LLC, P.O. Box 327, Titusville, NJ 08560. Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.
Postmaster: Send address changes to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345.
PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.
Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: [email protected].
Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: [email protected].
Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.
Advertising in PharmaVoice: To advertise in PharmaVoice please contact our Advertising Department at P.O. Box 327, Titusville, NJ 08560, or telephone us at 609.730.0196. E-mail: [email protected].